$ADVB
Advanced Biomed Inc.
CIK:0001941029|SEC Filings
Unaudited Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|||
| Operating expenses: | ||||||
| Research and development expenses | $ (243,226) | $ (219,966) | $ (665,140) | $ (600,056) | ||
| General and administrative expenses | (276,610) | (347,541) | (646,213) | (475,093) | ||
| Total operating expenses | (519,836) | (567,507) | (1,311,353) | (1,075,149) | ||
| Other income (expense): | ||||||
| Interest (expense) income | (112) | 9,094 | 15,287 | |||
| Gain on disposal of subsidiaries | 7,346,684 | |||||
| Other income (expense), net | 31,006 | (629,992) | 210,132 | (702,244) | ||
| Total other income (expense), net | 30,894 | (629,992) | 7,565,910 | (686,957) | ||
| Income (loss) before tax expense | (488,942) | (1,197,499) | 6,254,557 | (1,762,106) | ||
| Income tax expense | ||||||
| Income (loss) from continuing operations | (488,942) | (1,197,499) | 6,254,557 | (1,762,106) | ||
| Income (loss) from discontinued operations, net of tax | (186,375) | (272,479) | (795,252) | |||
| Net income (loss) for the period | (488,942) | (1,383,874) | 5,982,078 | (2,557,358) | ||
| Other comprehensive income | ||||||
| Foreign currency translation (loss) gain, net of taxes | (30,963) | 39,696 | (497,905) | 168,954 | ||
| Total comprehensive income (loss) | $ (519,905) | $ (1,344,178) | $ 5,484,173 | $ (2,388,404) | ||
| Income (loss) per share: | ||||||
| continuing operations, basic (in Dollars per share) | [1] | $ (0.38) | $ (1.17) | $ 5.45 | $ (1.75) | |
| continuing operations, diluted (in Dollars per share) | [1] | (0.38) | (1.17) | 5.45 | (1.75) | |
| discontinued operations, basic (in Dollars per share) | [1] | (0.18) | (0.24) | (0.79) | ||
| discontinued operations, diluted (in Dollars per share) | [1] | (0.18) | (0.24) | (0.79) | ||
| Total income (loss) per share, basic (in Dollars per share) | [1] | (0.38) | (1.35) | 5.21 | (2.54) | |
| Total income (loss) per share, diluted (in Dollars per share) | [1] | $ (0.38) | $ (1.35) | $ 5.21 | $ (2.54) | |
| Weighted average number of shares of common stock in computing net income (loss) per share | ||||||
| Basic (in Shares) | [1] | 1,284,923 | 1,023,955 | 1,148,654 | 1,007,810 | |
| Diluted (in Shares) | [1] | 1,284,923 | 1,023,955 | 1,148,654 | 1,007,810 | |
| ||||||